查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1663514

生物辅料市场，按产品、来源、应用、国家和地区 - 2025 年至 2032 年全球产业分析、市场规模、市场份额和预测

Biologic Excipients Market, By Product, By Source, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年生物辅料市场规模价值为 29.8343 亿美元，2025 年至 2032 年期间复合年增长率为 5.90%。

生物辅料市场-市场动态

生物药物需求不断成长

生物药物的需求不断增长是生物辅料市场成长的主要驱动力，因为生物製剂可以为癌症、自体免疫疾病和罕见遗传疾病等复杂疾病提供有针对性的高效治疗。生物药物，包括单株抗体、疫苗和细胞疗法，具有分子结构复杂、对环境因素较为敏感的特点，因此使用专门的辅料对于确保稳定性、有效性和安全性至关重要。这种需求是由于全球慢性病发病率不断上升以及老年人口不断增加需要先进的治疗方案所致。根据世界卫生组织 (WHO) 的数据，慢性病占全球所有死亡人数的约 71%，凸显了对创新生物製剂治疗的迫切需求。作为回应，政府和医疗保健组织正在大幅增加对生物药物研发的投资。例如，在美国，生物製剂占2023年前100种处方药销售额的近50％，反映出其市场主导地位日益增强。这一趋势直接影响生物辅料市场，因为製造商需要复杂的辅料解决方案来增强药物配方和输送。因此，在创新疗法的不断发展以及满足严格的监管和品质标准的需求的推动下，生物辅料市场将实现大幅成长。

生物辅料市场-关键见解

  • 根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 5.90%
  • 根据产品细分，预计稳定剂将在 2024 年占据最大市场份额
  • 根据应用细分，生物製药生产是 2024 年的领先细分市场
  • 从地区来看，北美是 2024 年最大的收入来源

生物辅料市场-細項分析：

全球生物辅料市场根据产品、来源、应用和地区进行细分。

根据产品，市场分为五类：增溶剂、稳定剂、防腐剂、缓衝剂和载体。稳定剂在市场上占据主导地位，因为它们在防止蛋白质聚集、氧化和变性方面发挥关键作用，而这些都是敏感生物药物的常见问题。它们能够增强药物稳定性并延长保质期，因此在生物製剂中不可或缺。

根据应用，市场分为三类：生物製药生产、研发和临床试验。生物製药生产占据市场主导地位，因为它代表了最大和最关键的应用领域，需要专门的赋形剂来确保生物药物在製造过程中的稳定性、有效性和可扩展性。对创新生物疗法和大规模生产的需求不断增长，推动了该领域辅料的广泛使用。

生物辅料市场-地理洞察

北美占据市场主导地位，主要归功于其成熟的製药和生物技术产业、大量的研发投入、以及需要生物疗法的慢性病发病率的不断上升。美国拥有主要参与者和先进的研究设施，占了相当大的市场份额。此外，美国 FDA 对生物製剂的快速批准等有利的政府措施和监管支持进一步促进了市场成长。欧洲是另一个主要地区，其驱动力来自强大的生物製药生产能力、药物开发创新以及欧洲药品管理局 (EMA) 等机构的支持性监管政策。德国、法国和英国等国家在该地区生物药物开发和生产方面处于领先地位。由于製药製造业的不断扩张、生物研发投入的不断增加以及医疗保健支出的不断增长，预计亚太地区将出现最快的增长。中国和印度等国家正在成为主要参与者，并透过政府支持的措施来促进当地生物製品的生产和出口。人们对先进疗法的认识不断提高，以及合约製造组织（CMO）数量的不断增加促进了区域成长。

生物辅料市场-竞争格局：

生物辅料市场的特点是竞争激烈，这种竞争是由持续创新、技术进步以及对复杂生物製剂的高品质专用辅料的日益关注所推动的。市场参与者根据产品组合竞争，提供符合生物製药应用严格监管标准的稳定剂、增溶剂和防腐剂。开发具有增强的稳定性和改善的生物相容性的多功能辅料是获得市场份额的关键竞争策略。辅料生产商和生物製药公司之间的伙伴关係、协作和策略联盟很常见，从而实现客製化解决方案和联合创新。此外，生物药品製造外包趋势的兴起为合约研究和製造组织（CRO 和 CMO）创造了成长机会，从而加剧了市场动态。公司也致力于扩大其地理影响力，以利用新兴市场（尤其是亚太地区）的快速成长。在监管压力和环境问题的推动下，绿色和永续辅料生产的创新正在成为关键的差异化因素。此外，对先进研究设施的投资和对不断发展的监管准则的遵守增强了竞争优势。

最新动态：

  • 2024 年 7 月，安捷伦科技公司宣布达成最终协议，以 9.25 亿美元收购加拿大合约开发和製造组织 (CDMO) BIOVECTRA。此次策略性收购旨在透过整合 BIOVECTRA 在生物製剂、高效活性药物成分和其他标靶治疗分子方面的专业知识来扩展安捷伦的生物製药解决方案。
  • 2024年11月，科莱恩在2024年CPHI印度展会上推出了一系列高性能辅料，以满足印度医疗保健市场日益增长的需求。这些赋形剂专为敏感活性药物成分 (API)、肠外製剂和无色应用而设计，注重纯度和生物利用度。该公司正在利用印度的製造能力来提供符合全球监管标准的客製化解决方案，确保生物製剂和复杂药物製剂的功效和安全性。
  • 2024年10月，三星生物製剂推出了高浓度配方平台，旨在推动高剂量生物药物的开发。该平台旨在提高高浓度药物的输送和疗效，简化开发流程并满足对此类疗法日益增长的需求。它支持生物製剂的製造和配方，确保更好的稳定性和可扩展性。

目录

第 1 章：生物辅料市场概览

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 生物辅料市场产品片段
    • 生物辅料市场片段（依来源）
    • 生物辅料市场片段（依应用）
    • 生物辅料市场（按国家/地区）摘要
    • 生物辅料市场片段（按区域）
  • 竞争洞察

第 3 章：生物辅料关键市场趋势

  • 生物辅料市场驱动因素
    • 市场驱动因素的影响分析
  • 生物辅料市场限制
    • 市场限制的影响分析
  • 生物辅料市场机会
  • 生物辅料市场未来趋势

第 4 章：生物辅料产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：生物辅料市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：生物辅料市场格局

  • 2024 年生物辅料市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：生物辅料市场 - 按产品分类

  • 概述
    • 按产品细分的份额分析
    • 增溶剂
    • 稳定剂
    • 防腐剂
    • 缓衝区
    • 承运商
    • 其他的

第 8 章：生物辅料市场 - 按来源

  • 概述
    • 按来源分類的细分市场占有率分析
    • 动物源性
    • 人类衍生
    • 微生物来源
    • 合成的

第 9 章：生物辅料市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 生物製药生产
    • 研究与开发
    • 临床试验

第 10 章：生物辅料市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物辅料主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品划分）
    • 北美市场规模与预测，依来源划分
    • 北美市场规模与预测，按应用划分
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物辅料主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品划分）
    • 欧洲市场规模与预测，按来源
    • 欧洲市场规模与预测，按应用划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物辅料主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依产品划分）
    • 亚太地区市场规模及预测（依来源划分）
    • 亚太地区市场规模及预测（按应用划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲生物辅料主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品划分）
    • 拉丁美洲市场规模及预测（按来源划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲生物辅料主要製造商
    • MEA 市场规模及预测（按国家/地区划分）
    • MEA 市场规模及预测（依产品划分）
    • MEA 市场规模和预测，按来源划分
    • MEA 市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-生物辅料产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Dow Chemical Company
    • BASF SE
    • Evonik Industries AG
    • Lonza Group
    • Wacker Chemie AG
    • Asahi Kasei Corporation
    • Clariant International Ltd.
    • Croda International Plc
    • Ingredion Incorporated
    • Fuji Chemical Industry Co. Ltd.
    • Nippon Fine Chemical Co. Ltd.
    • DSM Nutritional Products
    • Protex International
    • Lubrizol Corporation
    • Ashland Global Holdings Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4716

REPORT HIGHLIGHT

Biologic Excipients Market size was valued at US$ 2,983.43 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

Biologic Excipients are non-active components used in the formulation of biologic drugs to enhance their stability, solubility, and overall performance. Unlike active pharmaceutical ingredients (APIs), these excipients do not produce therapeutic effects but play a critical role in ensuring the efficacy, safety, and shelf-life of biologic products. Given the sensitive nature of biologics such as proteins, peptides, and monoclonal antibodies, the selection of appropriate excipients is crucial in overcoming challenges related to stability, degradation, and delivery. The need for biologic excipients arises from the complex and fragile structure of biological molecules, which are highly susceptible to environmental factors like heat, light, and pH changes. Excipients act as stabilizers to prevent protein aggregation, oxidation, or denaturation, thus preserving the drug's potency. Additionally, solubilizers and surfactants improve the solubility of poorly soluble compounds, enhancing their bioavailability and therapeutic effectiveness. Preservatives and buffering agents are essential for maintaining product sterility and pH balance, ensuring safe administration to patients. The importance of biologic excipients lies in their ability to optimize drug formulation, support large-scale production, and extend shelf-life without compromising product quality. Their proper use enhances patient outcomes, regulatory compliance, and the commercial success of biologic therapies in modern medicine.

Biologic Excipients Market- Market Dynamics

Increasing demand for biologic drugs

The increasing demand for biologic drugs is a key driver in the growth of the biologic excipients market, as biologics offer targeted, highly effective treatments for complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. Biologic drugs, including monoclonal antibodies, vaccines, and cell therapies, are characterized by their complex molecular structures and greater sensitivity to environmental factors, making the use of specialized excipients essential to ensure stability, efficacy, and safety. This demand is fueled by the rising prevalence of chronic diseases globally and the expanding geriatric population requiring advanced therapeutic solutions. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all deaths worldwide, highlighting the urgent need for innovative biologic-based treatments. In response, governments and healthcare organizations are significantly increasing investments in biologic drug research and development. For instance, in the United States, biologics accounted for nearly 50% of the top 100 prescription drug sales in 2023, reflecting their growing market dominance. This trend directly impacts the biologic excipients market, as manufacturers require sophisticated excipient solutions to enhance drug formulation and delivery. As a result, the biologic excipients market is poised for significant growth, driven by the continuous development of innovative therapies and the need to meet stringent regulatory and quality standards.

Biologic Excipients Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)
  • Based on Product segmentation, Stabilizers was predicted to show maximum market share in the year 2024
  • Based on Application segmentation, Biopharmaceutical Production was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Biologic Excipients Market- Segmentation Analysis:

The Global Biologic Excipients Market is segmented on the basis of Product, Source, Application and Region.

The market is divided into five categories based on Product: Solubilizers, Stabilizers, Preservatives, Buffers and Carriers. Stabilizers dominate the market due to their critical role in preventing protein aggregation, oxidation, and denaturation, which are common issues with sensitive biologic drugs. Their ability to enhance drug stability and extend shelf life makes them indispensable in biologic formulations.

The market is divided into three categories based on Application: Biopharmaceutical Production, Research and Development and Clinical Trials. Biopharmaceutical Production dominates the market because it represents the largest and most critical application segment, requiring specialized excipients to ensure the stability, efficacy, and scalability of biologic drugs during manufacturing. The growing demand for innovative biologic therapies and large-scale production needs drives the extensive use of excipients in this sector.

Biologic Excipients Market- Geographical Insights

North America dominates the market, primarily due to its well-established pharmaceutical and biotechnology industries, extensive R&D investments, and the rising prevalence of chronic diseases requiring biologic therapies. The United States, with major players and advanced research facilities, accounts for a significant market share. Additionally, favorable government initiatives and regulatory support, such as the U.S. FDA's fast-track approvals for biologics, further boost market growth. Europe represents another major region, driven by strong biopharmaceutical production capabilities, innovation in drug development, and supportive regulatory policies from agencies like the European Medicines Agency (EMA). Countries like Germany, France, and the UK lead the region in biologic drug development and production. The Asia-Pacific region is expected to witness the fastest growth due to the expanding pharmaceutical manufacturing sector, increasing investments in biologic R&D, and growing healthcare expenditures. Countries such as China and India are emerging as key players, with government-backed initiatives to boost local biologic production and exports. Rising awareness about advanced therapies and an increasing number of contract manufacturing organizations (CMOs) contribute to regional growth.

Biologic Excipients Market- Competitive Landscape:

The Biologic Excipients Market is characterized by intense competition driven by continuous innovation, technological advancements, and a growing focus on high-quality, specialized excipients tailored for complex biologic formulations. Market players compete based on product portfolios, offering stabilizers, solubilizers, and preservatives that meet stringent regulatory standards for biopharmaceutical applications. The development of multifunctional excipients with enhanced stability properties and improved biocompatibility is a key competitive strategy to gain market share. Partnerships, collaborations, and strategic alliances between excipient producers and biopharmaceutical companies are common, enabling customized solutions and joint innovation. Additionally, the rising trend of outsourcing biologic drug manufacturing has created growth opportunities for contract research and manufacturing organizations (CROs and CMOs), intensifying market dynamics. Companies are also focusing on expanding their geographic presence to capitalize on the rapid growth in emerging markets, especially in Asia-Pacific. Innovation in green and sustainable excipient production, driven by regulatory pressures and environmental concerns, is becoming a critical differentiator. Furthermore, investments in advanced research facilities and adherence to evolving regulatory guidelines enhance competitive positioning.

Recent Developments:

  • In July 2024, Agilent Technologies Inc. announced a definitive agreement to acquire BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. This strategic acquisition aims to expand Agilent's biopharma solutions by incorporating BIOVECTRA's expertise in biologics, highly potent active pharmaceutical ingredients, and other targeted therapeutic molecules.
  • In November 2024, Clariant introduced a range of high-performance excipients at CPHI India 2024 to address the growing needs of the Indian healthcare market. These excipients are designed for sensitive active pharmaceutical ingredients (APIs), parenteral formulations, and colorless applications, with an emphasis on purity and bioavailability. The company is leveraging India's manufacturing capabilities to deliver customized solutions that meet global regulatory standards, ensuring the efficacy and safety of biologics and complex drug formulations.
  • In October 2024, Samsung Biologics launched a high-concentration formulation platform aimed at advancing the development of high-dose biologic drugs. This platform is designed to improve the delivery and efficacy of drugs with higher concentrations, streamlining the development process and meeting the increasing demand for such therapies. It supports both the manufacturing and formulation of biologics, ensuring better stability and scalability.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGIC EXCIPIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Dow Chemical Company
  • BASF SE
  • Evonik Industries AG
  • Lonza Group
  • Wacker Chemie AG
  • Asahi Kasei Corporation
  • Clariant International Ltd.
  • Croda International Plc
  • Ingredion Incorporated
  • Fuji Chemical Industry Co. Ltd.
  • Nippon Fine Chemical Co. Ltd.
  • DSM Nutritional Products
  • Protex International
  • Lubrizol Corporation
  • Ashland Global Holdings Inc.
  • Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Solubilizers
  • Stabilizers
  • Preservatives
  • Buffers
  • Carriers
  • Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY SOURCE - MARKET ANALYSIS, 2019 - 2032

  • Animal-derived
  • Human-derived
  • Microbial-derived
  • Synthetic

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Production
  • Research and Development
  • Clinical Trials

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biologic Excipients Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologic Excipients Market Snippet by Product
    • 2.1.2. Biologic Excipients Market Snippet by Source
    • 2.1.3. Biologic Excipients Market Snippet by Application
    • 2.1.4. Biologic Excipients Market Snippet by Country
    • 2.1.5. Biologic Excipients Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologic Excipients Key Market Trends

  • 3.1. Biologic Excipients Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologic Excipients Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologic Excipients Market Opportunities
  • 3.4. Biologic Excipients Market Future Trends

4. Biologic Excipients Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologic Excipients Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biologic Excipients Market Landscape

  • 6.1. Biologic Excipients Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologic Excipients Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Solubilizers
    • 7.1.3. Stabilizers
    • 7.1.4. Preservatives
    • 7.1.5. Buffers
    • 7.1.6. Carriers
    • 7.1.7. Others

8. Biologic Excipients Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 8.1.2. Animal-derived
    • 8.1.3. Human-derived
    • 8.1.4. Microbial-derived
    • 8.1.5. Synthetic

9. Biologic Excipients Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Production
    • 9.1.3. Research and Development
    • 9.1.4. Clinical Trials

10. Biologic Excipients Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biologic Excipients Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biologic Excipients Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biologic Excipients Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Biologic Excipients Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Biologic Excipients Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biologic Excipients Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Dow Chemical Company
    • 11.2.2. BASF SE
    • 11.2.3. Evonik Industries AG
    • 11.2.4. Lonza Group
    • 11.2.5. Wacker Chemie AG
    • 11.2.6. Asahi Kasei Corporation
    • 11.2.7. Clariant International Ltd.
    • 11.2.8. Croda International Plc
    • 11.2.9. Ingredion Incorporated
    • 11.2.10. Fuji Chemical Industry Co. Ltd.
    • 11.2.11. Nippon Fine Chemical Co. Ltd.
    • 11.2.12. DSM Nutritional Products
    • 11.2.13. Protex International
    • 11.2.14. Lubrizol Corporation
    • 11.2.15. Ashland Global Holdings Inc.
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us